Aurinia Pharmaceuticals
Biopharma, Biotechnology, Health Care
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of kidney diseases. Their lead product, LUPKYNIS® (voclosporin), is specifically designed to treat lupus nephritis. Aurinia is committed to advancing scientific understanding and improving patient outcomes in nephrology. The company's mission emphasizes addre
Key facts
- Employees
- 160
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Public (AUPH)
- Company page
Recent activity at Aurinia Pharmaceuticals
Companies similar to Aurinia Pharmaceuticals
- Parabilis Medicines · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Aquestive Therapeutics, Inc. · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Disc · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- TerSera · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Redx · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Aurinia Pharmaceuticals: questions and answers
What does Aurinia Pharmaceuticals do?
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of kidney diseases. Their lead product, LUPKYNIS® (voclosporin), is specifically designed to treat lupus nephritis. Aurinia is committed to advancing scientific understanding and improving patient outcomes in nephrology. The company's mission emphasizes addre
How many employees does Aurinia Pharmaceuticals have?
Aurinia Pharmaceuticals has about 160 employees.
What is the latest news on Aurinia Pharmaceuticals?
On Aug 29, 2026, Aurinia completes acquisition of Kezar Life Sciences
Is Aurinia Pharmaceuticals a public company?
Yes. Aurinia Pharmaceuticals is publicly traded under the ticker AUPH.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy